DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1ACETAMINOPHEN
02 1ALTOPREV
03 1BUDESONIDE
04 5BUPROPION HYDROCHLORIDE
05 1CARDIZEM LA
06 1CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE
07 1CHLORPHENIRAMINE MALEATE
08 1CIPROFLOXACIN EXTENDED RELEASE
09 1COVERA-HS
10 1DILTIAZEM HYDROCHLORIDE
11 1DITROPAN XL
12 1DYANAVEL XR 10
13 1DYANAVEL XR 15
14 1DYANAVEL XR 20
15 1DYANAVEL XR 5
16 1FELODIPINE
17 1FORTAMET
18 1GLIPIZIDE
19 1GLUMETZA
20 1HYDROMORPHONE HYDROCHLORIDE
21 1ISOSORBIDE MONONITRATE
22 1LEVETIRACETAM
23 1LORATADINE AND PSEUDOEPHEDRINE SULFATE
24 1METFORMIN HYDROCHLORIDE
25 2METHYLPHENIDATE HYDROCHLORIDE
26 3METOPROLOL SUCCINATE
27 1MINOCYCLINE HYDROCHLORIDE
28 1MORPHABOND ER
29 6MORPHINE SULFATE
30 1MS CONTIN
31 1NAPROXEN SODIUM
32 1NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE
33 1OPANA ER
34 1OSMOLEX ER
35 2OXYBUTYNIN CHLORIDE
36 1OXYCONTIN
37 1PALIPERIDONE
38 2PAROXETINE HYDROCHLORIDE
39 1PAXIL CR
40 1PSEUDOEPHEDRINE HYDROCHLORIDE
41 6RANOLAZINE
42 1SUDAFED 24 HOUR
43 2TRAMADOL HYDROCHLORIDE
44 1TUXARIN ER
45 1VENLAFAXINE HYDROCHLORIDE
46 2VERAPAMIL HYDROCHLORIDE
47 1WELLBUTRIN SR
48 1ZOLPIDEM TARTRATE
49 1ZYBAN
01 119516
02 120021
03 120358
04 120552
05 120711
06 120897
07 120936
08 121316
09 121392
10 121574
11 121610
12 121748
13 122272
14 140829
15 173568
16 174330
17 174769
18 174862
19 175077
20 175153
21 175395
22 175416
23 175706
24 175896
25 175932
26 176159
27 176518
28 176644
29 176702
30 176720
31 176733
32 176862
33 177298
34 177686
35 177809
36 177855
37 177873
38 177991
39 190153
40 190942
41 191272
42 191424
43 191427
44 1200503
45 1201384
46 1203059
47 1204161
48 1205457
49 1205634
50 1205794
51 1206122
52 1206323
53 1206544
54 1206674
55 1209410
56 1209993
57 4210526
58 1211009
59 1211291
60 1211829
61 1211865
62 1212133
63 1212889
64 1213085
65 1213473
66 1213517
67 1216174
01 61No
02 9Yes
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : METHYLPHENIDATE HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 213473
Country : US
Patented : No
Drug : FORTAMET
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 21574
Country : US
Patented : No
Drug : CHLORPHENIRAMINE MALEATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 40829
Country : US
Patented : No
Drug : ALTOPREV
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 21316
Country : US
Patented : No
Drug : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 213085
Country : US
Patented : No
CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
Drug : CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 77991
Country : US
Patented : No
Drug : MORPHINE SULFATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 74769
Country : US
Patented : No
Drug : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 212889
Country : US
Patented : No
Drug : MORPHABOND ER
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 206544
Country : US
Patented : Yes
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Drug : SUDAFED 24 HOUR
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 20021
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
